# Star Health & Allied Insurance Company share price today (Star Health & Allied Insurance Company Ltd, NSE: STARHEALTH)

> Star Health & Allied Insurance Company share price today: ₹530.50 at the NSE close on 4 November 2026, up 8.6% in a year. Star Health & Allied Insurance Company (NSE: STARHEALTH) is worth ₹31,250 crore, trades at a P/BV of 3.0 and has closed between ₹425.15 and ₹603.25 over the past 52 weeks. > Star Health & Allied Insurance Company Ltd's results are improving, while its P/BV is near the low end of its own history over 4.5 years, higher than only 0% of past readings. STARHEALTH · Finance - Non Life Insurance · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/star-health-allied-insurance-company-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: ₹530.50 (+8.6% in a year)
- P/BV: 3.0× (lower than 100% of the last 4.5 years)
- Revenue (Sep 2026): ₹5,341 Cr (+17.1% on a year ago)
- Profit (Sep 2026): ₹265 Cr (+231.3% on a year ago)
- Net margin: 5.0% (+3.2 points on a year ago)
- ROE: 8%, FY26
- ROA: 3.33%, latest

The main question: foreign institutions moved −1.8 percentage points over 8 quarters while the business went the other way. ## What is the Star Health & Allied Insurance Company share price today? Star Health & Allied Insurance Company Ltd's share price was ₹530.50 at the close on 4 November 2026. It has been rising for 28 weeks. That is 0.2% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹425 and ₹603, and at that close it sat 59% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 1 week in a row. Over the last 4.9 years the share price moved −42% while the NIFTY 500 moved +46%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Star Health & Allied Insurance Company this quarter? Two changes stood out: revenue up on a year earlier for 12 quarters in a row (every quarter we can compare) and indian funds and insurers (DIIs) cut their stake for 4 quarters in a row. 1. Revenue up on a year earlier for 12 quarters in a row (every quarter we can compare) In the September 2026 quarter revenue was ₹5,341 crore, +17.1% on a year earlier. Why: Revenue rose because the company sold more new retail health policies and more of its customers were buying insurance for the first time. Next results: check whether fresh business growth stays at 20% plus through the second half and over the long term. From the earnings call on 28 Oct 2026. 2. Indian funds and insurers (DIIs) cut their stake for 4 quarters in a row From 21.1% to 18.8% of the company by the September 2026 quarter. ## What are Star Health & Allied Insurance Company's latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Star Health & Allied Insurance Company reported total income of ₹5,341 crore, up 17.1% from ₹4,561 crore a year earlier, and a profit of ₹265 crore, up 231.3% from ₹80.0 crore. ### Star Health & Allied Insurance Company results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Total income | ₹5,341 crore | ₹4,561 crore | +17.1% |
| Profit | ₹265 crore | ₹80.0 crore | +231.3% |
| Earnings per share | ₹4.50 | ₹1.35 | +233.3% |
| Net margin | 5.0% | 1.8% | +3.2 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Star Health & Allied Insurance Company's management discussed these results on a call held on 28 October 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 September 2026). Income and profit in ₹ crore.)

## What is the Star Health & Allied Insurance Company share price history? Star Health & Allied Insurance Company closed at ₹530.50 on 4 November 2026, up 8.6% from ₹488.65 a year earlier (7 November 2025) and down 41.5% over five years. Its highest weekly close since December 2021 was ₹906.85 on 10 December 2021. ### Star Health & Allied Insurance Company share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹530.40 | 0.0% |
| 1 month ago · 1 Oct 2026 | ₹537.70 | −1.3% |
| 6 months ago · 8 May 2026 | ₹520.15 | +2.0% |
| 1 year ago · 7 Nov 2025 | ₹488.65 | +8.6% |
| 3 years ago · 3 Nov 2023 | ₹546.05 | −2.8% |
| 5 years ago · 10 Dec 2021 | ₹906.85 | −41.5% |
| Earliest and highest weekly close in our records · 10 Dec 2021 | ₹906.85 | −41.5% |
| Lowest weekly close since December 2021 · 4 Apr 2025 | ₹348.05 | +52.4% |
| 52-week high (weekly close) · 10 Jul 2026 | ₹603.25 | −12.1% |
| 52-week low (weekly close) · 23 Jan 2026 | ₹425.15 | +24.8% |

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (263 weekly closes from 10 December 2021 to 4 November 2026.)

## What is the latest news on Star Health & Allied Insurance Company? 4 Nov 2026: Star Health & Allied Insurance Company closed at ₹530.50, up 0.0% on the week and down 1.3% on the month. 28 Oct 2026: Star Health & Allied Insurance Company held its results call for July to September 2026. Management guided: Fresh business growth 20% plus through H2 and consistently long term. ### Earlier

- Results for July to September 2026: Total income up 17.1% and profit up 231.3% on a year earlier. ## What dividend does Star Health & Allied Insurance Company pay? Star Health & Allied Insurance Company has paid no dividend on the NSE since its first NSE close in our records (10 December 2021), the start of the period we checked. No. Star Health & Allied Insurance Company Ltd paid out 0% of its profit as dividends in each of its last 12 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 5 November 2026.)

## What did Star Health & Allied Insurance Company management say on the latest results call? On the call for July to September 2026, held on 28 October 2026, Star Health & Allied Insurance Company's management guided: Fresh business growth 20% plus through H2 and consistently long term. > “Q2 FY27 marked the fifth successive quarter of improvement in our loss ratios and underwriting results. This is clear evidence of a structural turnaround in our operating performance.”
> Anand Roy, on the call for July to September 2026

### What management guided

- ROE from mid-teens to high-teens over time on combined-ratio focus. - Complete repricing of balance book this year with further loss-linked corrections. - Insurance finance expense nil going forward after treatment change. - Equity allocation capped at 15% over medium term with flexibility if extremely attractive. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/44717/Conference Call/CC-Oct26.pdf). (From the call for July to September 2026, 28 October 2026.)

## What to watch in Star Health & Allied Insurance Company's next results? When Star Health & Allied Insurance Company reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Fresh growth having at aspired pace through H2 as GST base normalises - per activation and policy-count focus. - What to check (from the call)
- Fresh growth having at aspired pace through H2 as GST base normalises - per activation and policy-count focus. - Renewal book staying below triple-digit combined with loss-cost discipline intact against earned growth on vintage strength. - Final distribution expense rules landing awaited with base-definition clarity and compliance intact without extra drag. ## Which stock lists is Star Health & Allied Insurance Company on? Star Health & Allied Insurance Company is on one of our India lists: Small & mid cap stocks. [Small & mid cap stocks Size rank in India: 269](https://www.sectoralpha.in/small-cap-stocks-india)

## Is Star Health & Allied Insurance Company profitable? Star Health & Allied Insurance Company Ltd earned ₹265 Cr of net profit in the Sep 2026 quarter, +231.3% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹557 Cr. Over 10 years profit has grown 15.1% a year on average. That is 5.0% of the quarter's revenue. The same quarter a year earlier earned ₹80.0 Cr. For the full year, FY26 profit was ₹557 Cr (−13.8% on the year before). Why profit moved: revenue changed +17.1% on a year earlier and the margin moved +3.2 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +2,804.1% and revenue +13.5%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Star Health & Allied Insurance Company make, and is it growing? Star Health & Allied Insurance Company Ltd reported ₹5,341 Cr of income in the Sep 2026 quarter, +17.1% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 10 years it has grown 27.3% a year on average. The last full year, FY26, came in at ₹17,825 Cr. The last four reported quarters add to ₹20,055 Cr. FY26 revenue was ₹17,825 Cr, +10.7% on the year before. Recent pace: the last four quarters grew +13.5% on average, against 27.3% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +13.5%, against +15.1% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +43.6%, against +10.6% a year (accelerating). ## How much does Star Health & Allied Insurance Company keep from what it earns? Star Health & Allied Insurance Company Ltd's net margin was 5.0% in the Sep 2026 quarter, 3.2 percentage points higher than the same quarter a year ago. Across 12 years it has been between −21.5% and 8.6%. The latest quarter is within that range. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of Star Health & Allied Insurance Company's loans have gone bad? Star Health & Allied Insurance Company Ltd does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Star Health & Allied Insurance Company's loan book growing? Star Health & Allied Insurance Company Ltd's revenue was ₹17,825 Cr in FY26, +10.7% on the year before, so the loan book is growing. The latest quarter was +17.1% on a year earlier. The net margin on that income is 5.0%, +3.2 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Gross NPA is the loan-quality figure this page uses. ## What is Star Health & Allied Insurance Company's P/BV ratio, and how does it compare with its own history? Star Health & Allied Insurance Company Ltd's P/BV is 3.0×, about the lowest it has ever been. Its usual P/BV (the middle reading) is 4.8×, over 4.5 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is low: this lender earns about 8% a year on its equity. A lender that earns less on its net worth is valued lower for each rupee of it, and that gap usually closes only if returns improve. Why the multiple is where it is: over the past year book value grew while the price moved +8.6%. Price and book value moved together, so the multiple stayed in its range. Where the price move came from: over 3 years the price moved −1.0% a year; about +15.3% a year came from book-value growth and about −16.3 percentage points from the multiple (the market paying less). The split is approximate (price return minus book-value growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the book value trend underneath matters more than the multiple. ## Is the Star Health & Allied Insurance Company business getting better or worse? Star Health & Allied Insurance Company Ltd's business is turning around. Profit growth has swung from −14.8% at its low to +43.6%, improving for 3 quarters in a row, with ROE steady at 8.6%. This is based on 12 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. ## What is Star Health & Allied Insurance Company management's track record? FY24 profit +37% to ₹845 crore. GWP grew from ₹12,952 crore (FY23) to ₹16,716 crore (FY25), consistent ~14% GWP yearly growth. Combined ratio improving trend (96.7% FY24 → 92.7% January to March 2024). FY25 GWP ₹17,553 crore. No major guidance misses found in public domain; business model is predictable (health insurance) with stable claim ratios. IRDAI actions are reputational risks but have not derailed financial performance. Management track record: credible on financial delivery; weak on cybersecurity/IT infrastructure. ### Regulatory and governance record

No SEBI fraud/scam orders found against Star Health promoters. Key regulatory actions are from IRDAI (insurance regulator not SEBI): (1) IRDAI fined ₹3.39 crore for cybersecurity violations (Jul 2025), dual penalty + formal warning, violations under IRDAI Information & Cyber Security Guidelines 2023. (2) IRDAI issued show cause notice in Dec 2024 for alleged norm violations (stock dropped 5%). (3) Aug 2024 cyberattack, data breach affecting 31M+ customers; Madras HC proceedings underway. These are operational/regulatory issues, not promoter fraud. No SEBI enforcement. (Checked 12 April 2026.)

## How much does Star Health & Allied Insurance Company earn on its equity and assets? We do not have a clean yearly return-on-equity history for Star Health & Allied Insurance Company Ltd. For an insurer in particular, the usual bank ratios do not fit, so this page does not force them or estimate a series. The revenue, margin and ownership sections show what this company does report. ## Does Star Health & Allied Insurance Company have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Star Health & Allied Insurance Company shareholding pattern? Foreign institutions cut their stake in Star Health & Allied Insurance Company Ltd by 1.8 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 15.9% of the company. Domestic institutions moved +1.7 points over the same period, to 18.8%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −1.8 points over 8 quarters, to 15.9%; Domestic institutions: +1.7 points over 8 quarters, to 18.8%; Promoters: +0.3 points over 8 quarters, to 58.0%. Why the owners changed: foreign institutions moved −1.8 points and domestic institutions +1.7 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is Star Health & Allied Insurance Company from balance-sheet trouble? For Star Health & Allied Insurance Company Ltd, the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Star Health & Allied Insurance Company rank in its industry? 58.6 out of 100, rank 1 of 4 in Finance - Non Life Insurance, with 88% of the evidence available. Star Health & Allied Insurance Company Ltd scores 58.6 out of 100 against the 4 companies it is compared with in Finance - Non Life Insurance, ranking 1. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 26.5 + 14.9 + 3.2 + 14 = 58.6. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Star Health & Allied Insurance Company compared with? Star Health & Allied Insurance Company ranks 1 of 4 Finance - Non Life Insurance companies on the 4-Factor Sector Score, with 58.6 out of 100. 1. Star Health & Allied Insurance Company Ltd this page STARHEALTH · quiet · Evidence leans up · 88% evidence 58.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.5/35 · Income 13.5% · Profit 43.6% · 86% evidence Capital efficiency 14.9/25 · ROA 3.7% · ROE 7.6% · GNPA n/a · 72% evidence Valuation 3.2/20 · P/BV 2.99× · P/BV÷ROE 0.39 · 100% evidence Relative strength 14.0/20 · Lead over its industry 7.7% · Lead over NIFTY 500 8.3% · 1 year 7.3% · 100% evidence · 4 of 12 weeks ahead Exact sum: 26.5 + 14.9 + 3.2 + 14 = 58.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [General Insurance Corporation of India](https://www.sectoralpha.in/stocks/general-insurance-corporation-of-india) GICRE · quiet · Evidence leans down · 86% evidence 45.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 6.7/35 · Income 6.3% · Profit -6.4% · 86% evidence Capital efficiency 19.5/25 · ROA 2.4% · ROE 14.6% · GNPA n/a · 72% evidence Valuation 17.9/20 · P/BV 0.74× · P/BV÷ROE 0.05 · 90% evidence Relative strength 1.5/20 · Lead over its industry -12.3% · Lead over NIFTY 500 -11.3% · 1 year -16.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 6.7 + 19.5 + 17.9 + 1.5 = 45.6 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 3. [ICICI Lombard General Insurance Company Ltd](https://www.sectoralpha.in/stocks/icici-lombard-general-insurance-company-ltd) ICICIGI · turning · Evidence leans down · 71% evidence 45.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 8.7/35 · Income 14% · Profit -8.8% · 86% evidence Capital efficiency 20.0/25 · ROA 1.7% · ROE 16.6% · GNPA n/a · 72% evidence Valuation 9.4/20 · P/BV 4.19× · P/BV÷ROE 0.25 · 90% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -6.7% · 1 year -20.7% · 25% evidence · 2 of 12 weeks ahead Exact sum: 8.7 + 20 + 9.4 + 7.5 = 45.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [New India Assurance Company Ltd](https://www.sectoralpha.in/stocks/new-india-assurance-company-ltd) NIACL · basing · Evidence leans down · 75% evidence 36.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.9/35 · Income 5.7% · Profit -80% · 52% evidence Capital efficiency 5.0/25 · ROA -0.6% · ROE 4.9% · GNPA n/a · 68% evidence Valuation 8.0/20 · P/BV 0.93× · P/BV÷ROE 0.19 · 100% evidence Relative strength 12.1/20 · Lead over its industry 0.6% · Lead over NIFTY 500 1.3% · 1 year -15% · 100% evidence · 5 of 12 weeks ahead Exact sum: 10.9 + 5 + 8 + 12.1 = 36 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Finance - Non Life Insurance](https://www.sectoralpha.in/sectors/finance-non-life-insurance), all 4 compared on one page. ## Which companies are close to Star Health & Allied Insurance Company in size? Star Health & Allied Insurance Company is the 3rd largest of 4 Finance - Non Life Insurance companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: ICICI Lombard General Insurance Company and General Insurance Corporation of India. Just below it: New India Assurance Company. ### Finance - Non Life Insurance companies close in size

1. [ICICI Lombard General Insurance Company Ltd](https://www.sectoralpha.in/stocks/icici-lombard-general-insurance-company-ltd) ₹78,998 crore
2. [General Insurance Corporation of India](https://www.sectoralpha.in/stocks/general-insurance-corporation-of-india) ₹54,536 crore
3. Star Health & Allied Insurance Company Ltd ₹31,221 crore
4. [New India Assurance Company Ltd](https://www.sectoralpha.in/stocks/new-india-assurance-company-ltd) ₹26,193 crore

[All 4 Finance - Non Life Insurance companies, largest first](https://www.sectoralpha.in/sectors/finance-non-life-insurance#all-companies)

### Companies close in size in other industries

1. [Container Corporation Of India Ltd](https://www.sectoralpha.in/stocks/container-corporation-of-india-ltd) ₹31,520 crore · Logistics
2. [Syrma SGS Technology Ltd](https://www.sectoralpha.in/stocks/syrma-sgs-technology-ltd) ₹31,341 crore · Consumer Electronics - EMS
3. Star Health & Allied Insurance Company Ltd ₹31,221 crore
4. [United Breweries Ltd](https://www.sectoralpha.in/stocks/united-breweries-ltd) ₹31,208 crore · Alcoholic Beverages
5. [Wockhardt Ltd](https://www.sectoralpha.in/stocks/wockhardt-ltd) ₹30,895 crore · Pharma - Formulators

## What else do people ask about Star Health & Allied Insurance Company? ### What is Star Health & Allied Insurance Company's share price today? Star Health & Allied Insurance Company Ltd's share price is ₹530.50, +8.6% over the past year. The whole company is worth ₹31,250 Cr on the market. In the last 52 weeks it traded between ₹425 to ₹603; today it is 59% of the way up from the low, 0.2% below its 200-day average (as of 4 November 2026). ### What were Star Health & Allied Insurance Company's latest quarterly results? Star Health & Allied Insurance Company Ltd reported total income of ₹5,341 Cr and net profit of ₹265 Cr for the Sep 2026 quarter. Income rose 17.1% and profit rose 231.3% compared with a year earlier. Earnings per share were ₹4.50 (as of 4 November 2026). ### What is Star Health & Allied Insurance Company's market cap? Star Health & Allied Insurance Company Ltd's market capitalisation is ₹31,250 Cr at a share price of ₹530.50. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Star Health & Allied Insurance Company performing? Star Health & Allied Insurance Company Ltd's share price has been rising for 28 weeks. In its latest quarter, income rose 17.1% and profit rose 231.3% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 1 week running (as of 4 November 2026). ### Will Star Health & Allied Insurance Company's share price go up? This page does not forecast Star Health & Allied Insurance Company Ltd's share price. What it shows instead: the share price is ₹530.50, and it has been rising for 28 weeks. Its P/BV of 3.0× is higher than 0% of its own last 5 years (as of 4 November 2026). ### Who owns Star Health & Allied Insurance Company? Promoters own 58.0% of Star Health & Allied Insurance Company Ltd, foreign institutions 15.9%, domestic institutions 18.8% and the public 7.4% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 1.8 percentage points over 8 quarters (as of 4 November 2026). ### Where is Star Health & Allied Insurance Company in its business cycle? Star Health & Allied Insurance Company Ltd's FY26 net margin was 3.1%, against a 12-year range of −21.5% to 8.6%: the middle of its own range, neither a peak nor a low. The latest quarter was 5.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Star Health & Allied Insurance Company story? The main question: foreign institutions moved −1.8 percentage points over 8 quarters while the business went the other way. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Star Health & Allied Insurance Company a stock worth studying right now? What the numbers show: Star Health & Allied Insurance Company Ltd's results are improving, while its P/BV is near the low end of its own history over 4.5 years, higher than only 0% of past readings. The main open question: whether the owners’ moves turn back in line with the business. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ### Is there a Star Health & Allied Insurance Company share price forecast for 2026? What management itself guided: Fresh business growth 20% plus through H2 and consistently long term. ### Where does this page get Star Health & Allied Insurance Company's management information? From Star Health & Allied Insurance Company's results calls, its filings and public records on governance, each dated on the page. Management’s plans are shown as plans, never as results. ## Lists

- Small & mid cap stocks: https://www.sectoralpha.in/small-cap-stocks-india

This is research, not advice. We’re not SEBI-registered.